Leadership Team

The Leadership Team at Palleon Pharmaceuticals is responsible for setting the strategic direction and vision of the company, driving innovation in glyco-immune checkpoint inhibitor development, and ensuring successful execution of research and clinical initiatives. Comprising influential leaders such as the CEO, Chief Medical Officer, and Chief Scientific Officer, the team collaborates to advance cutting-edge cancer treatments while overseeing operations, regulatory compliance, and stakeholder engagement.